Self-management of immunomodulatory drug treatment in multiple myeloma patients.

Author: AhoSerge, BoulinMathieu, BoutetMérédith, CaillotDenis, ChretienMarie-Lorraine, CosmeEdouard, CransacAmélie, FavennecCamille, GiroudMaurice, GueneauPauline, SchrederLaure

Paper Details 
Original Abstract of the Article :
OBJECTIVE: Immunomodulatory drugs (IMIDs: thalidomide, lenalidomide and pomalidomide) are widely used in patients with multiple myeloma (MM). The aim of our study was to validate a questionnaire to evaluate the self-capacity of MM patients to manage IMID treatment including side effects. METHODS: W...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/ecc.13356

データ提供:米国国立医学図書館(NLM)

Empowering Multiple Myeloma Patients: Self-Management of Immunomodulatory Drug Treatment

Multiple myeloma, a type of cancer that affects the bone marrow, can be a challenging diagnosis. This research focuses on the self-management of immunomodulatory drug (IMID) treatment for multiple myeloma patients, a crucial aspect of their care and well-being.

Validating a Questionnaire for Self-Management Skills

The study developed and validated a questionnaire to assess the self-management skills of multiple myeloma patients taking IMIDs. This tool helps healthcare professionals identify patients who might need extra support to manage their treatment and potential side effects.

A Camel's Perspective on Patient Empowerment

This research highlights the importance of patient empowerment in managing chronic diseases. By providing tools and resources to support self-management, we can equip individuals with the knowledge and skills they need to navigate their health journey.

Dr. Camel's Conclusion

This research underscores the value of self-management tools and resources for multiple myeloma patients. By empowering individuals to take an active role in their treatment, we can improve their overall well-being and support their journey to a healthier future.

Date :
  1. Date Completed 2021-09-29
  2. Date Revised 2021-09-29
Further Info :

Pubmed ID

33159353

DOI: Digital Object Identifier

10.1111/ecc.13356

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.